Profil
Cedric Burg worked as the Vice President of Global Clinical Development at Chiltern International Ltd. He also held the position of Vice President and Head of Global Clinical Operations at BioXcel Therapeutics, Inc. Prior to these roles, he served as the Chief Operating Officer at Innovaderm Research, Inc. Dr. Burg completed his undergraduate degree at American University.
He then pursued a graduate degree at the University of Rennes and obtained a doctorate degree from the University of Nantes.
Tidigare kända positioner av Cedric Burg
| Företag | Position | Slut |
|---|---|---|
| BIOXCEL THERAPEUTICS, INC. | Företagsledare/Principal | - |
Innovaderm Research, Inc.
Innovaderm Research, Inc. BiotechnologyHealth Technology Operates as a clinical research organization specialized in dermatology | Verksamhetschef | - |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Företagsledare/Principal | - |
Cedric Burgs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Kopplade företag
| Privata företag | 6 |
|---|---|
American University
American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Rennes
University of Rennes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Provides clinical research services | Commercial Services |
University of Nantes
University of Nantes Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Innovaderm Research, Inc.
Innovaderm Research, Inc. BiotechnologyHealth Technology Operates as a clinical research organization specialized in dermatology | Health Technology |
BioXcel Therapeutics, Inc.
BioXcel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops transformative medicines in neuroscience and immuno-oncology | Health Technology |
















